USD
+$0.00
(+0.00%
)At Close (As of Sep 9, 2025)
$471.76M
Market Cap
-
P/E Ratio
-1.28
EPS
$7.79
52 Week High
$2.82
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $27M |
Total Revenue | $85M |
Cost Of Revenue | $58M |
Costof Goods And Services Sold | $58M |
Operating Income | -$68M |
Selling General And Administrative | $46M |
Research And Development | $49M |
Operating Expenses | $95M |
Investment Income Net | - |
Net Interest Income | $5.5M |
Interest Income | $5.5M |
Interest Expense | $24K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $11M |
Income Before Tax | -$81M |
Income Tax Expense | $18K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$81M |
Comprehensive Income Net Of Tax | - |
Ebit | -$81M |
Ebitda | -$70M |
Net Income | -$81M |
Field | Value (USD) |
---|---|
Total Assets | $270M |
Total Current Assets | $203M |
Cash And Cash Equivalents At Carrying Value | $91M |
Cash And Short Term Investments | $91M |
Inventory | $4M |
Current Net Receivables | $8.1M |
Total Non Current Assets | $67M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | $94M |
Other Current Assets | $5.9M |
Other Non Current Assets | - |
Total Liabilities | $67M |
Total Current Liabilities | $31M |
Current Accounts Payable | $6.4M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $9.4M |
Total Non Current Liabilities | $36M |
Capital Lease Obligations | $43M |
Long Term Debt | - |
Current Long Term Debt | $1.7M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $44M |
Other Current Liabilities | $12M |
Other Non Current Liabilities | $1.3M |
Total Shareholder Equity | $203M |
Treasury Stock | - |
Retained Earnings | -$550M |
Common Stock | $9K |
Common Stock Shares Outstanding | $59M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$45M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $11M |
Capital Expenditures | $1.6M |
Change In Receivables | - |
Change In Inventory | $4.4M |
Profit Loss | - |
Cashflow From Investment | -$35M |
Cashflow From Financing | $115M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$81M |
Field | Value (USD) |
---|---|
Gross Profit | $27M |
Total Revenue | $85M |
Cost Of Revenue | $58M |
Costof Goods And Services Sold | $58M |
Operating Income | -$68M |
Selling General And Administrative | $46M |
Research And Development | $49M |
Operating Expenses | $95M |
Investment Income Net | - |
Net Interest Income | $5.5M |
Interest Income | $5.5M |
Interest Expense | $24K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $11M |
Income Before Tax | -$81M |
Income Tax Expense | $18K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$81M |
Comprehensive Income Net Of Tax | - |
Ebit | -$81M |
Ebitda | -$70M |
Net Income | -$81M |
Sector: HEALTHCARE
Industry: DIAGNOSTICS & RESEARCH
Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California.